Road to First-in-Human Trials for Biologics

Are you a biotech startup eager to navigate the complex landscape of first-in-human clinical trials for biologics? Our upcoming program is designed to equip you with valuable insights needed to understand and prepare for this critical phase of large molecule drug development. As competition for funding is fierce, startups are expected to demonstrate a clear blueprint for their clinical trials strategy, and we want you to be ready.

Large molecule biologics often have unique characteristics that may require specialized procedures. Understanding and navigating these pathways while ensuring compliance with stringent and ever-changing regulations can be challenging. How do you adapt your trials strategy to current market conditions?

This event is tailored for biotech startups venturing into first-in-human trials with a biologics asset, but should also provide valuable insights for other early innovators and first-time entrepreneurs active in this space. We also welcome stakeholders supporting these startups.